Amyl Therapeutics has closed $22.3 million in Series A financing, led by Belgium-based Noshaq, with participation from Merieux Participations, Sambrinvest, and other private investors. Additionally,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.